Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Well Do You Use Cash, Amgen?
Motley Fool
Monday, August 23, 2010 - 5:32pm
tags:
Amgen, Biogen Idec, Genzyme
Johnson & Johnson: More Than Just a Band-Aid for the Dividend Portfolio
Seeking Alpha
Monday, August 23, 2010 - 5:29pm
tags:
JNJ, dividends
Why Abbott Is More Than a Dividend Stock
Minyanville
Monday, August 23, 2010 - 5:27pm
tags:
Abbott Laboratories
Glaxo starts final clinical trial of shingles vaccine
Reuters
Monday, August 23, 2010 - 12:19pm
tags:
GSK, clinical trials vaccines, shingles
Cumberland Pharmaceutical shares fall after FDA extends review of Acetadote
Yahoo/AP
Monday, August 23, 2010 - 12:10pm
tags:
FDA, Cumberland, Acetadote, liver failure
Alexion gets FDA OK for Rhode Island facility
Yahoo/AP
Monday, August 23, 2010 - 11:49am
tags:
Alexion, Rhode Island, FDA
U.S. biotech faces fierce international competition
Fierce Biotech
Monday, August 23, 2010 - 11:47am
tags:
biotech, R&D, Canada, Singapore, Sweden, Denmark
Genzyme Publishes Positive Phase II Gaucher Results
Biosmash
Monday, August 23, 2010 - 11:44am
tags:
Genzyme, Gaucher disease, eliglustat tartrate
Avandiagate: Glaxo And A Controversial Memo
Pharmalot
Monday, August 23, 2010 - 11:43am
tags:
GSK, Avandia, diabetes
Sales Reps Continue To Make Fewer Visits To Docs
Pharmalot
Monday, August 23, 2010 - 10:35am
tags:
drug reps, physicians, Novartis
Big Pharma's Top 5 Emerging Market Deals
Fierce Pharma
Monday, August 23, 2010 - 10:32am
tags:
emerging markets, Abbott Laboratories, Piramal Healthcare, India, GSK, Laboratorios Phoenix, Argentina, Novartis, China, Zhejiang Tianyuan Bio-Pharmaceutical, Brazil, Amgen, South Korea, Dong-A Pharma
FDA eyes safety of Novartis Parkinson's med
Fierce Pharma
Monday, August 23, 2010 - 10:29am
tags:
FDA, Parkinson's Disease, Novartis, Stalevo
JAZZ, CPIX, EPCT: Drug Makers Slammed By FDA Obstacles
Barron's
Monday, August 23, 2010 - 10:28am
tags:
Jazz Pharmaceuticals, FDA, Cumberland, EpiCept
Renegade Researcher Says Alzheimer’s Drugs From Bristol-Myers, Pfizer May Be Unsafe Or Ineffective
Forbes
Monday, August 23, 2010 - 10:06am
tags:
Pfizer, Alzheimer's disease, Bristol-Myers Squibb, anti-amyloid, Eli Lilly
Patients Should Stay on Pfizer's Lipitor, Not Switch to Generic, Study Says
Bloomberg
Monday, August 23, 2010 - 9:29am
tags:
statins, Pfizer, cholesterol, Lipitor, generics
Once Again, Preemption Is Not A Defense For Wyeth
Pharmalot
Monday, August 23, 2010 - 9:20am
tags:
Wyeth, preemption, FDA, Redux, Pfizer
Roche to buy high-tech imaging company
Swissinfo
Monday, August 23, 2010 - 9:19am
tags:
Roche, M&A, imaging, Bioimagene
Warner Chilcott shares rise in pre-market trading after drugmaker updates on special dividend
Yahoo/AP
Monday, August 23, 2010 - 9:17am
tags:
Warner Chilcott, dividends
The Economics of Drug Discovery: 'First in Class' vs. 'Best in Class'
Seeking Alpha
Sunday, August 22, 2010 - 12:27pm
tags:
drug discovery
Lilly's Glimmers of Light Unlikely to Bring Future Growth
Seeking Alpha
Sunday, August 22, 2010 - 12:26pm
tags:
Eli Lilly, Cymbalta, Strattera

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.